|
National Stock Number(NSN): 6505-01-312-7869 (6505013127869, 013127869)
| NIIN: |
01-312-7869 |
Item Name: |
GLYBURIDE TABLETS |
INC: |
66764
|
| FSC: |
6505
|
Assignment Date: |
Dec-22-1989 |
CRIT: |
N |
IIG: |
66764 |
| ISC: |
2 |
Date Standardized: |
Dec-22-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Nov-01-2003 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-0941 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
DIABETA |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
DIABETA TABLETS |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00039-0051-11 |
04500
|
HOECHST-ROUSSEL PHARMACEUTICALS INC |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
K |
U |
1 |
A |
$15.12 |
PG |
|
C2201X- |
Jul-01-1995 |
H |
| DF |
JDC |
L |
|
K |
U |
1 |
F |
$15.12 |
PG |
|
------- |
Jun-01-1995 |
H |
| DM |
S9M |
L |
Z |
K |
U |
1 |
M |
$15.12 |
PG |
|
1354--1 |
Jan-01-1991 |
H |
| DN |
JDC |
L |
|
K |
U |
1 |
N |
$15.12 |
PG |
|
9L----- |
Mar-01-1990 |
H |
| DS |
JDC |
L |
|
K |
U |
1 |
D |
$15.12 |
PG |
|
------- |
Dec-01-1989 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100TT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.500 MILLIGRAMS GLYBURIDE ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
INDIVIDUALLY SEALED |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
GLYBURIDE TABLETS USP 2.5MG I.S. 100S PG |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
20.15 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
1.97 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
100 |
| FEAT |
SPECIAL FEATURES |
100 TABLETS PER PACKAGE |
| PKQT |
INTERMEDIATE PACKAGE QUANTITY |
10 |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUCB |
UNIT OF ISSUE CUBE |
0.0197 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.2015 POUNDS |
| THPE |
THERAPEUTIC EQUIVALENT |
DIABETA BY HOECHST-ROUSSEL |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
| MC15 |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-19-2003 |
3 |
H |
|
|
|
|
|